I've been a resident since the beginning of COVID and now with the DEA unwinding it's relaxed prescribing guidelines, there's been some confusion among my residency class about what is required for Rxs of controlled substances in our clinic going forward. We work in a general outpatient psychiatry clinic and a good number of our patients are virtual and on controlled meds like stimulants or benzos. Some of them may have seen a previous resident in the past but haven't seen their current prescriber face to face before. I've heard different versions of requirements from different attendings, e.g. they need to be seen in person for the med initiation but can be virtual q3 months after that, or they need to be seen q3 months either in-person or virtual, or YOU need to see them in person at least once before continuing the existing prescription, or they need in person once a year, etc. etc.

I am wondering if anyone knows the what the real rules are for residents in this kind of clinic setting, or where it can be found. I found this document which is pretty dense but I don't think it addresses the question of carrying forward an existing prescription with a new trainee-prescriber in the same clinic